Semax is a synthetic regulatory heptapeptide derived from an ACTH fragment. Preclinical research has explored its relationship with BDNF/TrkB signalling, neurotrophin expression, memory, learning and neuronal responses to experimental stress or ischemia. Human evidence remains limited, and established clinical safety and efficacy have not been confirmed.

Research basis: https://pubmed.ncbi.nlm.nih.gov/16996037/

Strictly for laboratory research only. Not intended for human or veterinary use.